Cargando…

Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways

Background and Aims: The disease progression of nonalcoholic fatty liver disease (NAFLD) from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH) is driven by multiple factors. Berberine (BBR) is an ancient Chinese medicine and has various beneficial effects on metabolic diseases, includi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yanyan, Tai, Yun-Ling, Zhao, Derrick, Zhang, Yuan, Yan, Junkai, Kakiyama, Genta, Wang, Xuan, Gurley, Emily C., Liu, Jinze, Liu, Jinpeng, Liu, Jimin, Lai, Guanhua, Hylemon, Phillip B., Pandak, William M., Chen, Weidong, Zhou, Huiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912096/ https://www.ncbi.nlm.nih.gov/pubmed/33494295 http://dx.doi.org/10.3390/cells10020210

Ejemplares similares

Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes
por: Wang, Yanyan, et al.
Publicado: (2020)

Mitochondrial Cholesterol Metabolites in a Bile Acid Synthetic Pathway Drive Nonalcoholic Fatty Liver Disease: A Revised “Two-Hit” Hypothesis
por: Kakiyama, Genta, et al.
Publicado: (2023)

RNA binding protein HuR protects against NAFLD by suppressing long noncoding RNA H19 expression
por: Wang, Yanyan, et al.
Publicado: (2022)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Berberine Reduces Neurotoxicity Related to Nonalcoholic Steatohepatitis in Rats
por: Ghareeb, Doaa A., et al.
Publicado: (2015)

The acidic pathway of bile acid synthesis: Not just an alternative pathway(☆)
por: Pandak, William M., et al.
Publicado: (2019)

Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions
por: Li, Xiaojiaoyang, et al.
Publicado: (2020)

Inhibition of P-Glycoprotein by HIV Protease Inhibitors Increases Intracellular Accumulation of Berberine in Murine and Human Macrophages
por: Zha, Weibin, et al.
Publicado: (2013)

Berberine Inhibits HIV Protease Inhibitor-Induced Inflammatory Response by Modulating ER Stress Signaling Pathways in Murine Macrophages
por: Zha, Weibin, et al.
Publicado: (2010)

Metabolomics Profiling to Investigate the Pharmacologic Mechanisms of Berberine for the Treatment of High-Fat Diet-Induced Nonalcoholic Steatohepatitis
por: Li, Jian, et al.
Publicado: (2015)

Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver disease
por: Minowa, Kei, et al.
Publicado: (2023)

Reduction of the HIV Protease Inhibitor-Induced ER Stress and Inflammatory Response by Raltegravir in Macrophages
por: Zhang, Xiaoxuan, et al.
Publicado: (2014)

Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats
por: Li, Donghao, et al.
Publicado: (2017)

Long Noncoding RNA H19: A Novel Oncogene in Liver Cancer
por: Wang, Yanyan, et al.
Publicado: (2023)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Gut microbial composition can differentially regulate bile acid synthesis in humanized mice
por: Kang, Dae Joong, et al.
Publicado: (2017)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Berberine ameliorates non-alcoholic steatohepatitis in ApoE(−/−) mice
por: Yang, Jin, et al.
Publicado: (2017)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
por: Xiang, Hui, et al.
Publicado: (2022)

Targeting MRG15 for the treatment of nonalcoholic steatohepatitis
por: Zhang, Yao, et al.
Publicado: (2022)

Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis
por: Mai, Weijian, et al.
Publicado: (2020)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
por: Parthasarathy, Gopanandan, et al.
Publicado: (2020)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Establishment and Comparison of Juvenile Female Mouse Models of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Zhou, Lishan, et al.
Publicado: (2018)

Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease
por: Machado, Mariana Verdelho, et al.
Publicado: (2015)

Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis
por: Yang, Rui-Xu, et al.
Publicado: (2019)

Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis
por: Liu, Wenli, et al.
Publicado: (2018)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Identification of Novel Regulatory Cholesterol Metabolite, 5-Cholesten, 3β,25-Diol, Disulfate
por: Ren, Shunlin, et al.
Publicado: (2014)

Thiazolidinediones for nonalcoholic steatohepatitis: A meta-analysis of randomized clinical trials
por: He, Lingling, et al.
Publicado: (2016)

Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
por: Li, Haiou, et al.
Publicado: (2020)

Wilson's disease masquerading as nonalcoholic steatohepatitis
por: Mahmood, Sabina, et al.
Publicado: (2009)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
por: Lam, Mindy C.W., et al.
Publicado: (2012)

The effect of β-caryophyllene on nonalcoholic steatohepatitis
por: Arizuka, Naoya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_skkv7vnt0t6rtlrp6cvipgj7mm